Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromhexine in hospitalized patients with COVID-19
IRCT20200317046797N4Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of bromhexine in coronavirus disease 2019 (COVID-19) and coronavirus pneumonia (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Symptoms of the disease, Mortality rate and 1 more. Started Apr 2020; status: completed.
02
Drugs
bromhexine
03
Conditions
coronavirus disease 2019 (COVID-19)coronavirus pneumonia
Beyond the preview
Go deeper on IRCT20200317046797N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200317046797N4.